CD10 (MME) Human shRNA Plasmid Kit (Locus ID 4311)

Specifications

Product Data
Product Name	CD10 (MME) Human shRNA Plasmid Kit (Locus ID 4311)
Locus ID	4311
UniProt ID	P08473
Synonyms	CALLA; CD10; CMT2T; NEP; SCA43; SFE
Vector	pGFP-C-shLenti
Format	Lentiviral plasmids
Kit Components	MME - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector(Gene ID = 4311). 5µg purified plasmid DNA per construct 29-mer scrambled shRNA cassette in pGFP-C-shLenti Vector, TR30021, included for free.
RefSeq	NM_000902, NM_007287, NM_007288, NM_007289, NM_001354642, NM_001354643, NM_001354644, NM_007288.1, NM_007288.2, NM_000902.1, NM_000902.2, NM_000902.3, NM_007287.1, NM_007287.2, NM_007289.1, NM_007289.2, BC101632, BC101658, BC106070, BC143465, BM151602, NM_000902.4, NM_007287.3, NM_007289.4, NM_007288.3
Summary	The protein encoded by this gene is a type II transmembrane glycoprotein and a common acute lymphocytic leukemia antigen that is an important cell surface marker in the diagnosis of human acute lymphocytic leukemia (ALL). The encoded protein is present on leukemic cells of pre-B phenotype, which represent 85% of cases of ALL. This protein is not restricted to leukemic cells, however, and is found on a variety of normal tissues. The protein is a neutral endopeptidase that cleaves peptides at the amino side of hydrophobic residues and inactivates several peptide hormones including glucagon, enkephalins, substance P, neurotensin, oxytocin, and bradykinin. [provided by RefSeq, Aug 2017]
shRNA Design	These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service.
Performance Guaranteed	OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred).

*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.